2020
DOI: 10.1016/j.jid.2019.12.021
|View full text |Cite
|
Sign up to set email alerts
|

Activation of SIRT1 Enhances Epidermal Permeability Barrier Formation through Ceramide Synthase 2– and 3–Dependent Mechanisms

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
13
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
7

Relationship

3
4

Authors

Journals

citations
Cited by 13 publications
(13 citation statements)
references
References 20 publications
0
13
0
Order By: Relevance
“…Skin surface lipids collected by D-Squame tape were analyzed using LC/MS/MS, and significant reduction of squalene was only observed in test product-treated site (Figure5A), which was consistent with the in vitro sebosuppressive activity of test peptide. Recently, we reported that SIRT1 activation peptide treatment stimulated the epidermal keratinocyte differentiation through ceramide synthase 2-and 3-mediated signaling 20. Higher resemblance in structural and biological properties of test peptide to those of previously reported one20 suggests similar differentiation promoting activity of test peptide in skin.…”
mentioning
confidence: 70%
See 1 more Smart Citation
“…Skin surface lipids collected by D-Squame tape were analyzed using LC/MS/MS, and significant reduction of squalene was only observed in test product-treated site (Figure5A), which was consistent with the in vitro sebosuppressive activity of test peptide. Recently, we reported that SIRT1 activation peptide treatment stimulated the epidermal keratinocyte differentiation through ceramide synthase 2-and 3-mediated signaling 20. Higher resemblance in structural and biological properties of test peptide to those of previously reported one20 suggests similar differentiation promoting activity of test peptide in skin.…”
mentioning
confidence: 70%
“…Recently, we reported that SIRT1 activation peptide treatment stimulated the epidermal keratinocyte differentiation through ceramide synthase 2-and 3-mediated signaling 20. Higher resemblance in structural and biological properties of test peptide to those of previously reported one20 suggests similar differentiation promoting activity of test peptide in skin. As a marker lipid for epidermal lipids constituting stratum corneum intercellular lamellar structure for skin barrier function, significant increase in cholesterol concentration was observed in test product-treated site after 8 weeks of usage (Figure5B).…”
mentioning
confidence: 70%
“…Because prior studies demonstrated that ceramides containing long-chain fatty acids (FAs) with 22–26 carbons in length are generated by CerS2 and CerS3 during de novo synthesis [ 13 ], we further determined the carbon chain lengths of FA of ceramides which were enhanced by PS. Consistent with prior findings [ 14 ], we showed that treatment with IL-4 significantly reduces the contents of ceramides with 22–26 carbon-containing FAs in cells ( Figure 4 A–E).…”
Section: Resultsmentioning
confidence: 99%
“…Ceramides, a class of sphingolipids containing a backbone of a sphingoid base (or referred to as sphingosine) that is linked to a fatty acid (FA) via an amide bond, are the predominant lipid comprising approximately 50% of the SC lipid content by mass, and the most effective structural component for the formation of the epidermal permeability barrier [ 12 ]. Ceramides are produced in the skin through two major pathways [ 13 ]: (i) the de novo synthesis pathway that is initiated by serine palmitoyltransferase (SPT) and catalyzes the condensation of serine and palmitoyl-CoA to produce 3-ketosphiganine, which is further metabolized to sphinganine. Sphinganine is then amide-linked (N-acylated) by ceramide synthases (CerSs) to generate ceramides with different acyl chain lengths; and (ii) the sphingomyelinase (SMase)-dependent hydrolysis of sphingomyelin, a key component of the plasma membrane.…”
Section: Discussionmentioning
confidence: 99%
“…Murine SC samples were collected by stripping off the D-Squame tape applied onto the back of the mice. SC samples were harvested from these D-Squame tapes and lysed in radioimmunoprecipitation assay buffer, and next, sphingolipids were extracted as per the procedures we have described previously [ 70 , 71 ]. The extracted lipids were dried in a vacuum system (Vision, Seoul, Republic of Korea), re-dissolved in methanol, and analyzed by liquid chromatography–electrospray ionization–tandem mass spectrometry (LC-ESI-MS/MS; API 3200 QTRAP mass; AB/Sciex, Framingham, MA, USA) in the selective ion monitoring mode.…”
Section: Methodsmentioning
confidence: 99%